by Madaline Spencer | Mar 11, 2025
Dawn Laney, genetic counselor at the Emory University School of Medicine, discusses a Fabry disease registry analysis examining growth in children being treated with agalsidase beta. Fabry disease is a rare lysosomal storage disease characterized by a...
by Madaline Spencer | Mar 10, 2025
Eric Wallace, MD, The University of Alabama at Birmingham, discusses an analysis of treatment comparisons between pegunigalsidase alfa versus other therapies for left ventricular mass index (LVMi) in Fabry disease. Fabry disease is a rare lysosomal...
by Madaline Spencer | Mar 7, 2025
Barbara Burton, MD, Professor of Pediatrics at Northwestern University Feinberg School of Medicine, discusses a recent study examining the effectiveness of idursulfase in young patients with mucopolysaccharidosis type II (MPS II). MPS II is a rare...
by Madaline Spencer | Mar 6, 2025
Karen Bean, Health Economist at Orchard Therapeutics, discusses a recent study comparing the effect of gene therapy in treated versus untreated sibling pairs with early-onset metachromatic leukodystrophy (MLD). MLD is a rare genetic condition...
by Madaline Spencer | Mar 5, 2025
Daniel Lewi, Founder of the CATS Foundation, and Kathleen Flynn, CEO of the National Tay-Sachs & Allied Diseases Association (NTSAD), discuss an industry-advocacy collaboration to optimize clinical trial design through a patient-centric approach. An...
